Search Results

You are looking at 11 - 19 of 19 items for :

  • "Mycosis fungoides" x
Clear All
Full access

Andy I. Chen and Ranjana H. Advani

Edited by Kerrin G. Robinson

with peripheral T-cell lymphomas (PTCL), the CONCEPT trial [abstract] . Blood 2007 ; 110 : Abstract 3449 . 19. Lundin J Hagberg H Repp R . Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis

Full access

lymphoma, mantle cell lymphoma, mycosis fungoides, and peripheral T-cell lymphoma will be published this year. Because of clinical advances over the past 3 decades, Hodgkin lymphoma, although rare, is curable in at least 80% of patients with 5-year

Full access

Andrew D. Zelenetz, Jeremy S. Abramson, Ranjana H. Advani, C. Babis Andreadis, John C. Byrd, Myron S. Czuczman, Luis Fayad, Andres Forero, Martha J. Glenn, Jon P. Gockerman, Leo I. Gordon, Nancy Lee Harris, Richard T. Hoppe, Steven M. Horwitz, Mark S. Kaminski, Youn H. Kim, Ann S. LaCasce, Tariq I. Mughal, Auyporn Nademanee, Pierluigi Porcu, Oliver Press, Leonard Prosnitz, Nashitha Reddy, Mitchell R. Smith, Lubomir Sokol, Lode Swinnen, Julie M. Vose, William G. Wierda, Joachim Yahalom and Furhan Yunus

expression of PAX5. CTCLs (Non-Anaplastic Morphology): Mycosis fungoides and Sézary syndrome are the most common types of CTCLs lacking anaplastic morphology. Primary CTCLs are very rare. In the WHO classification, 3 rare provisional entities are included

Full access

Hans C. Lee, Victor Mulanovich and Yago Nieto

E Jones RR . Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides . Bone Marrow Transplant 2007 ; 40 : 401 – 403 . 17

Full access

Ali Bazarbachi, Hamdy A. Azim, Hussain Alizadeh, Mahmoud Aljurf, Ibrahim Barista, Naeem A. Chaudhri, Zahira Fahed, Omar A. Fahmy, Ardeshir Ghavamzadeh, Mohamed H. Khalaf, Sami Khatib, Aghiad Kutoubi, Semra Paydas, Hanadi Rafii Elayoubi, Ghazi Zaatari, Hamdy M. Zawam and Andrew D. Zelenetz

chemotherapy is recommended (methotrexate, cytarabine, and corticosteroids). Cutaneous T-Cell Lymphomas Background Many patients with smoldering ATL can be misdiagnosed with mycosis fungoides or Sézary syndrome if HTLV-I serology is not

Full access

Steven M. Horwitz, Andrew D. Zelenetz, Leo I. Gordon, William G. Wierda, Jeremy S. Abramson, Ranjana H. Advani, C. Babis Andreadis, Nancy Bartlett, John C. Byrd, Luis E. Fayad, Richard I. Fisher, Martha J. Glenn, Thomas M. Habermann, Nancy Lee Harris, Francisco Hernandez-Ilizaliturri, Richard T. Hoppe, Mark S. Kaminski, Christopher R. Kelsey, Youn H. Kim, Susan Krivacic, Ann S. LaCasce, Matthew Lunning, Auayporn Nademanee, Oliver Press, Rachel Rabinovitch, Nishitha Reddy, Erin Reid, Kenneth Roberts, Ayman A. Saad, Lubomir Sokol, Lode J. Swinnen, Julie M. Vose, Joachim Yahalom, Nadeem Zafar, Mary Dwyer, Hema Sundar and Pierluigi Porcu

-cell lymphomas (CTCL; 10 patients with mycosis fungoides and 2 patients with PTCL-NOS with isolated skin involvement), resulting in an ORR of 67% (17% CR and 50% PR). 45 Histologically, responses were observed in 7 patients with CTCL and one patient with PTCL

Full access

Wing C. Chan and James O. Armitage

indolent course (e.g., mycosis fungoides), but most are aggressive lymphomas. Most reports of gene expression patterns have addressed peripheral T-cell lymphomas of nodal origin rather than those that begin in extranodal sites. T-cell anaplastic large

Full access

. Patient characteristics such as sex, alcohol use status, and PS are statistically significant predictors of PFS in patients with advanced HNC. Further study is underway. AB2017-74. Phototherapy Use Patterns and Costs Among Patients With Mycosis Fungoides

Full access

Andrew D. Zelenetz, Jeremy S. Abramson, Ranjana H. Advani, C. Babis Andreadis, Nancy Bartlett, Naresh Bellam, John C. Byrd, Myron S. Czuczman, Luis E. Fayad, Martha J. Glenn, Jon P. Gockerman, Leo I. Gordon, Nancy Lee Harris, Richard T. Hoppe, Steven M. Horwitz, Christopher R. Kelsey, Youn H. Kim, Ann S. LaCasce, Auayporn Nademanee, Pierluigi Porcu, Oliver Press, Barbara Pro, Nashitha Reddy, Lubomir Sokol, Lode J. Swinnen, Christina Tsien, Julie M. Vose, William G. Wierda, Joachim Yahalom and Nadeem Zafar

. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of